Subclinical primary aldosteronism and major adverse cardiovascular events: evidence for a continuum of renin-independent aldosterone excess and a proposal for early detection - Top-Institutions - MDSpire

Subclinical primary aldosteronism and major adverse cardiovascular events: evidence for a continuum of renin-independent aldosterone excess and a proposal for early detection

  • By

  • Atef Akoum

  • Mounir Hakim

  • Rola Kwayess

  • Bahaa El Deen Wehbeh

  • Lina Alaaeddine

  • Mohamed Nasser El Shabrawi

  • Ashesh Das

  • Akshay Kumar

  • Sreekant Avula

  • Abdallah Rebeiz

  • Jason Li

  • June 23, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital, Center for Adrenal Disorders
    Brigham and Women’s Hospital, Center for Adrenal Disorders

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology

  • #3

    International CONNsortium
    International CONNsortium

    N/A, N/A

    Key Differentiators

    • Endocrinology

  • #4

    SPAIN-ALDO Registry
    SPAIN-ALDO Registry

    N/A, N/A

    Key Differentiators

    • Endocrinology

  • #5

    German Conn's registry
    German Conn's registry

    N/A, N/A

    Key Differentiators

    • Endocrinology

Original Source(s)

Subclinical primary aldosteronism and major adverse cardiovascular events: evidence for a continuum of renin-independent aldosterone excess and a proposal for early detection

  • by Atef Akoum, Mounir Hakim, Rola Kwayess, Bahaa El Deen Wehbeh, Lina Alaaeddine, Mohamed Nasser El Shabrawi, Ashesh Das, Akshay Kumar, Sreekant Avula, Abdallah Rebeiz, Jason Li

  • June 23, 2026

Related Content

Association between region-specific epicardial adipose tissue and CT-derived fractional flow reserve-defined myocardial ischemia: a retrospective coronary CTA study stratified by hypertension and type 2 diabetes mellitus

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

The triglyceride-glucose–waist-to-height ratio is the strongest predictor of reduced kidney function in elderly hypertensive patients